Equisetin is an anti-obesity candidate through targeting 11β-HSD1.
Xu Z, Liu D, Liu D, Ren X, Liu H, Qi G, Zhou Y, Wu C, Zhu K, Zou Z, Yuan J, Lin W, Guo P.
Xu Z, et al.
Acta Pharm Sin B. 2022 May;12(5):2358-2373. doi: 10.1016/j.apsb.2022.01.006. Epub 2022 Jan 15.
Acta Pharm Sin B. 2022.
PMID: 35646525
Free PMC article.